Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
11/2008
11/05/2008EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
11/05/2008EP1987832A1 Sustained-release tablet composition of pramipexole
11/05/2008EP1987831A1 Compounds effecting glucokinase
11/05/2008EP1986498A2 Insecticidal substituted amino heterocyclic and heteroaryl derivatives
11/05/2008EP1858901B1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008CN101300253A Bicyclic derivatives as modulators of voltage gated ion channels
11/05/2008CN101300240A 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as beta 2 adrenoceptor agonists
11/05/2008CN101300239A 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as beta 2 adrenoceptor agonists
11/05/2008CN101298442A Acidamide compound based on 2-(2í»-hydroxyphenyl) benzoxazole, preparation and use thereof
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446118 depression, anxiety, genitourinary diaorders, pain; monoamine reuptake inhibitors, triple and/or dual reuptake inhibitors of norepinephrine, serotonin, and dopamine; 5-(3-Methylamino-1H-phenyl-propyl)-1H-indole-3-carbonitrile
11/04/2008US7446104 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/04/2008CA2400704C 8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
11/04/2008CA2376919C Arylthiazolidinedione and aryloxazolidinedione derivatives
10/2008
10/30/2008WO2008131134A1 Hydrazide compounds and uses thereof
10/30/2008WO2008130395A2 Desferrithiocin analogue actinide decorporation agents
10/30/2008WO2008130172A1 N- hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same
10/30/2008WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors
10/30/2008US20080269303 Diaryloxazole carboxamide derivatives for treating a disease selected from appetite disorder, metabolic disorder, gastrointestinal disorder, inflammatory phenomena, immune system disease, psychotic disorder, alcohol dependency and nicotine dependency
10/30/2008US20080269295 Substituted thiazoles and their use for producing drugs
10/30/2008US20080269283 Arylsulfones and uses related thereto
10/30/2008US20080269265 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080269219 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole
10/30/2008US20080269215 Bisamide Inhibitors of Hedgehog Signaling
10/30/2008US20080267879 Novel Imaging Tracers for Early Detection and Treatment of Amyloid Plaques Caused by Alzheimer's Disease and Related Disorders
10/30/2008US20080265758 Organometallic complexes and organic electroluminescence device using the same
10/30/2008CA2684837A1 Desferrithiocin analogue actinide decorporation agents
10/29/2008EP1985296A1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease
10/29/2008EP1984361A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
10/29/2008EP1983993A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/29/2008EP1983980A2 Thiazole and thiadiazole compounds for inflammation and immune-related uses
10/29/2008EP1562979B1 Tubulysins, method for producing the same and tubulysin preparations
10/29/2008EP1216228B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
10/29/2008CN101296914A Derivative having PPAR agonistic activity
10/29/2008CN101296913A Heterocyclic amide derivatives useful as microbiocides
10/29/2008CN101296911A Arylurea derivatives as modulators of chemokine receptor activity
10/29/2008CN101296908A Tricyclo substituted amides as glucokinase modulators
10/29/2008CN101296901A HIV-1 protease inhibitors, and methods of making and using them
10/29/2008CN101296892A PPAR active compounds
10/29/2008CN101293878A Benzothiazole amino benzenes compounds, preparation method and application thereof
10/29/2008CN101293877A Method for preparing tetrahydrothiazole diketone derivatives
10/29/2008CN101293874A Polyalcohol-filling material coupling additive agent
10/28/2008US7442797 Platinum complex and light emitting device
10/28/2008US7442794 Stereoisomers ; reacting with Lewis acid; purification
10/28/2008US7442715 Thiazole derivatives
10/28/2008US7442702 Prostaglandin agonists
10/28/2008US7442673 Reaction products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives
10/28/2008US7442447 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
10/23/2008WO2008126772A1 Therapeutic agent for hypertension
10/23/2008WO2008126770A1 Method for producing triarylcarboxylic acid derivative
10/23/2008WO2008126731A1 Aryl derivatives
10/23/2008WO2008125230A2 Insecticidal derivatives of substituted aminoheterocycles
10/23/2008WO2008096127A3 Bicyclo[2.2.1]hept-7-ylamine derivatives and their use as m3 muscarinic receptor modulators
10/23/2008WO2008021849A3 Novel compounds as antagonists or inverse agonists at opioid receptors
10/23/2008WO2007079960A9 Substituted thiazoles and their use for producing drugs
10/23/2008US20080262046 Amidopropoxyphenyl Orexin Receptor Antagonists
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261953 Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity
10/22/2008EP1982713A2 Substituted benzoxazoles and analogues as estrogenic agents
10/22/2008EP1982595A1 Insecticidal derivatives of substituted aminoheterocycles
10/22/2008EP1981866A1 Fungicide n-cycloalkyl-benzyl-amide derivatives
10/22/2008EP1981845A2 Sulfonamide derivatives to treat infection with hepatitis c virus
10/22/2008EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
10/22/2008EP1910351B1 Colourless water-soluble organic luminophores and intermediates thereof
10/22/2008EP1425265B1 Derivatives of c2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments
10/22/2008CN101291908A Immunosuppressant compounds and compositions
10/22/2008CN101289464A Process for recovering triphenyl phosphine oxide and 2-mercaptobenzothiazole from production waste liquid of cephalothin active ester
10/22/2008CN101289431A Thiazoline multithioether compounds with sterilization activity, synthetic method and applications
10/22/2008CN100427472C Aryl-heteroaromatic products, compositions containing same and use thereof
10/22/2008CN100427454C Method for producing difluoro-acetyl-acetic acid alkylesters
10/21/2008US7439535 Process for exchanging functional groups by halogen-metal exchange reaction
10/21/2008US7439408 Method for producing halogenated 2-(3-butenylsulphanyl)-1,3-thiazoles
10/21/2008US7439357 Reacting with ammonia and formaldehyde; hydrolysis; hexahydrotriazines
10/21/2008US7439263 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
10/21/2008US7439260 7-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
10/21/2008US7439259 e.g. 2-{4-[({2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}-2-methylpropanoic acid; peroxime proliferator activated receptor inhibitor; antidiabetic, hypoglycemic agent; dyslipidemia, syndrome X, heart failure, hypercholesteremia, insulin resistance
10/21/2008US7439250 such as lipoasparagine; liposomes
10/21/2008CA2330974C Energy transfer assay method and reagent
10/21/2008CA2296012C Epothilone derivatives
10/21/2008CA2171334C Substituted thiazolo[3,2-a]azepine derivatives
10/16/2008WO2008124393A1 Benzothiazole derivatives and their use as protein kinase inhibitors
10/16/2008WO2008124000A2 Thiazole derivatives as androgen receptor modulator compounds
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008123349A1 Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative
10/16/2008WO2008122787A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
10/16/2008WO2008122329A1 Uv-filter compounds
10/16/2008WO2008057862A3 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
10/16/2008WO2008024302A3 Compounds for treating proliferative disorders
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255213 4R)-2-(benzo[d][1,3]dioxol-5-yl)-N-decylthiazolidine-4-carboxamide; prostate cancer, breast cancer, ovarian cancer, skin cancer
10/16/2008US20080255202 Phenylthioacetic Acid Derivatives and Use Thereof
10/16/2008US20080255198 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
10/16/2008US20080255196 Pesticide Thiazolyloxy Substituted Phenylamidine Derivatives
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 337